{"result": {"id": "077d542b-48f1-40d3-adc7-8b3fb348bdea", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>中国<|>geo<|>中国是英克司兰和血脂康等药物的上市国家，也是相关研究的开展地\")\n##\n(\"entity\"<|>红曲<|>organization<|>红曲是血脂康的原料来源，从中提取天然洛伐他汀及其同系物\")\n##\n(\"entity\"<|>天然洛伐他汀<|>organization<|>天然洛伐他汀是血脂康的主要活性成分之一，具有降脂作用\")\n##\n(\"entity\"<|>VLDL-C<|>organization<|>VLDL-C是一种脂蛋白，烟酸和ω-3脂肪酸可降低其水平\")\n##\n(\"entity\"<|>HDL-C<|>organization<|>HDL-C是高密度脂蛋白胆固醇，烟酸可提高其水平\")\n##\n(\"entity\"<|>LDL-C<|>organization<|>LDL-C是低密度脂蛋白胆固醇，英克司兰和血脂康等药物可降低其水平\")\n##\n(\"entity\"<|>TG<|>organization<|>TG是甘油三酯，贝特类药物和ω-3脂肪酸可降低其水平\")\n##\n(\"entity\"<|>TC<|>organization<|>TC是总胆固醇，烟酸可降低其水平\")\n##\n(\"relationship\"<|>英克司兰<|>中国<|>英克司兰于2023年8月在中国获批上市<|>9)\n##\n(\"relationship\"<|>血脂康<|>中国<|>血脂康在中国冠心病二级预防研究中被证实具有降脂作用<|>8)\n##\n(\"relationship\"<|>血脂康<|>红曲<|>血脂康是从红曲中提取的中药制剂<|>9)\n##\n(\"relationship\"<|>血脂康<|>天然洛伐他汀<|>血脂康含有天然洛伐他汀及其同系物<|>8)\n##\n(\"relationship\"<|>烟酸<|>VLDL-C<|>烟酸可降低VLDL-C水平<|>7)\n##\n(\"relationship\"<|>烟酸<|>HDL-C<|>烟酸可提高HDL-C水平<|>7)\n##\n(\"relationship\"<|>烟酸<|>LDL-C<|>烟酸可降低LDL-C水平<|>7)\n##\n(\"relationship\"<|>烟酸<|>TC<|>烟酸可降低TC水平<|>7)\n##\n(\"relationship\"<|>ω-3脂肪酸<|>VLDL-C<|>ω-3脂肪酸可通过抑制VLDL-C生成或促进其清除来降低水平<|>8)\n##\n(\"relationship\"<|>ω-3脂肪酸<|>TG<|>ω-3脂肪酸可降低TG水平<|>8)\n##\n(\"relationship\"<|>贝特类药物<|>TG<|>贝特类药物主要用于治疗高TG血症，可降低TG水平约30%<|>8)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751559216, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 652, "prompt_tokens": 3258, "total_tokens": 3910, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 3200}, "prompt_cache_hit_tokens": 3200, "prompt_cache_miss_tokens": 58}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 47］。英克司兰于 2023 年 8 月在中国获 批上市，用于成年人原发性高胆固醇血症和混合型 血脂异常的治疗 。主要适用于他汀类药物治疗后 LDL?C 未达目标值，以及不能耐受或禁忌使用他汀 类药物的患者。\n　　（4）中医药类：临床实践和研究表明，中医药在 血脂管理中具有一定的价值 。血脂康作为一种从 红曲中提取的中药制剂，包括天然洛伐他汀及其同 系物，以及不饱和脂肪酸、麦角甾醇、类黄酮和其他 天然活性成分等［48］。 中国冠心病二级预防研究证 实血脂康具有明确的降脂作用，可降低心血管事件 和死亡风险［49］。血脂康安全性高，耐受性好，主要 不良反应为胃肠道不适，且较少导致肝酶、肌酶升 高［50］。对于他汀类药物不耐受的患者，血脂康可作 为替代或辅助治疗用药，如足量使用血脂康后血脂 仍未达目标值，可联合使用其他种类的降脂药物。\n　　此外，一些具有活血祛痰功效的中成药，如血 滞通胶囊［51］、绞股蓝总苷胶囊［52］和荷丹片等［53］，单 独使用也具有一定的降低胆固醇的作用，为血脂管 理提供了更多选择。\n2. 主要降低 TG 的药物\n　　（ 1）贝特类：贝特类药物主要用于治疗高 TG 血  症 ，可 降 低 TG 水 平 约 30%，同 时 对 总 胆 固 醇 和  HDL?C 水平也有轻微影响［54］。常见的贝特类物包  括非诺贝特 、吉非罗齐 、苯扎贝特和环丙贝特等 。 上述药物在效力、相互作用和不良反应方面各有特  点 。其中，非诺贝特不干扰他汀类药物代谢且不增  加不良反应风险，可作为与他汀类药物联合应用的  首选 。吉非罗齐则可用于不适用他汀类药物的患  者，需注意其可增加肌肉损害风险，与他汀类药物  联用需谨慎。\n　　（2）烟酸类：烟酸是一种水溶性维生素 B3，可 通过激活烟酸受体减少脂肪分解 。烟酸具有广谱 的调血脂作用，可降低 TC、TG、LDL?C 和 VLDL?C 水\n\n\n平，提高 HDL?C 水平［55］。烟酸尤其是缓释制剂常 见不良反应包括皮肤潮红、胃肠不适、腹泻和肝毒 性等。\n　　（3）处方级 ω?3 脂肪酸：处方级 ω?3 脂肪酸可通 过抑制 VLDL?C 生成 、促进 VLDL?C 清除或激活蛋 白脂肪酶活性，降低 TG 水平［56］。ω?\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>英克司兰<|>organization<|>英克司兰是一种药物，于2023年8月在中国获批上市，用于治疗成年人原发性高胆固醇血症和混合型血脂异常，适用于他汀类药物治疗后LDL-C未达目标值或不能耐受他汀类药物的患者)\n##\n(\"entity\"<|>血脂康<|>organization<|>血脂康是一种从红曲中提取的中药制剂，含有天然洛伐他汀及其同系物，以及其他天然活性成分，具有降脂作用，可降低心血管事件和死亡风险，安全性高，耐受性好)\n##\n(\"entity\"<|>中国冠心病二级预防研究<|>event<|>中国冠心病二级预防研究证实血脂康具有明确的降脂作用，可降低心血管事件和死亡风险)\n##\n(\"entity\"<|>血滞通胶囊<|>organization<|>血滞通胶囊是一种具有活血祛痰功效的中成药，单独使用具有一定的降低胆固醇的作用)\n##\n(\"entity\"<|>绞股蓝总苷胶囊<|>organization<|>绞股蓝总苷胶囊是一种具有活血祛痰功效的中成药，单独使用具有一定的降低胆固醇的作用)\n##\n(\"entity\"<|>荷丹片<|>organization<|>荷丹片是一种具有活血祛痰功效的中成药，单独使用具有一定的降低胆固醇的作用)\n##\n(\"entity\"<|>非诺贝特<|>organization<|>非诺贝特是一种贝特类药物，主要用于治疗高TG血症，可降低TG水平约30%，不干扰他汀类药物代谢且不增加不良反应风险)\n##\n(\"entity\"<|>吉非罗齐<|>organization<|>吉非罗齐是一种贝特类药物，可用于不适用他汀类药物的患者，需注意其可增加肌肉损害风险，与他汀类药物联用需谨慎)\n##\n(\"entity\"<|>苯扎贝特<|>organization<|>苯扎贝特是一种贝特类药物，主要用于治疗高TG血症)\n##\n(\"entity\"<|>环丙贝特<|>organization<|>环丙贝特是一种贝特类药物，主要用于治疗高TG血症)\n##\n(\"entity\"<|>烟酸<|>organization<|>烟酸是一种水溶性维生素B3，具有广谱的调血脂作用，可降低TC、TG、LDL-C和VLDL-C水平，提高HDL-C水平)\n##\n(\"entity\"<|>ω-3脂肪酸<|>organization<|>处方级ω-3脂肪酸可通过抑制VLDL-C生成、促进VLDL-C清除或激活蛋白脂肪酶活性，降低TG水平)\n##\n(\"relationship\"<|>血脂康<|>中国冠心病二级预防研究<|>中国冠心病二级预防研究证实血脂康具有明确的降脂作用<|>8)\n##\n(\"relationship\"<|>非诺贝特<|>吉非罗齐<|>非诺贝特和吉非罗齐都是贝特类药物，用于治疗高TG血症<|>6)\n##\n(\"relationship\"<|>非诺贝特<|>他汀类药物<|>非诺贝特不干扰他汀类药物代谢且不增加不良反应风险，可作为与他汀类药物联合应用的首选<|>7)\n##\n(\"relationship\"<|>吉非罗齐<|>他汀类药物<|>吉非罗齐可增加肌肉损害风险，与他汀类药物联用需谨慎<|>6)\n##\n(\"relationship\"<|>血脂康<|>他汀类药物<|>对于他汀类药物不耐受的患者，血脂康可作为替代或辅助治疗用药<|>7)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_a72872fead6e8d7fcf312a55545c6c497cb7c156ae3e851c0efe6cd6182fda11_v2"}